HomeAZNCF • OTCMKTS
add
AstraZeneca
Nakaraang pagsara
$131.47
Sakop ng araw
$130.75 - $133.40
Sakop ng taon
$118.16 - $175.00
Market cap
203.35B USD
Average na Volume
1.70K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Sa balita
SSE
0.12%
0.095%
1.94%
1.98%
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 13.56B | 18.04% |
Gastos sa pagpapatakbo | 7.79B | 4.64% |
Net na kita | 1.43B | 4.00% |
Net profit margin | 10.53 | -11.96% |
Kita sa bawat share | 2.08 | 140.46% |
EBITDA | 4.63B | 45.69% |
Aktuwal na % ng binabayarang buwis | 21.61% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 4.93B | -3.62% |
Kabuuang asset | 104.92B | 9.20% |
Kabuuang sagutin | 64.12B | 8.92% |
Kabuuang equity | 40.80B | — |
Natitirang share | 1.55B | — |
Presyo para makapag-book | 5.00 | — |
Return on assets | 7.92% | — |
Return on capital | 11.38% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 1.43B | 4.00% |
Cash mula sa mga operasyon | 3.38B | 8.64% |
Cash mula sa pag-invest | -1.51B | -24.00% |
Cash mula sa financing | -4.13B | -51.54% |
Net change in cash | -2.24B | -163.15% |
Malayang cash flow | 2.05B | -12.38% |
Tungkol
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden and Gaithersburg in Maryland, U.S.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Throughout the twentieth century, it grew into the largest pharmaceutical company in Sweden. Wikipedia
Itinatag
Abr 6, 1999
Headquarters
Website
Mga Empleyado
89,900